Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Conditions › Neurodegenerative diseases

Neurodegenerative diseases

17 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for Neurodegenerative diseases

11 trials tracked for Neurodegenerative diseases.

11Trials tracked
0Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 2 4 Other / NA 7
  1. Phase 2 AMX0035 in Patients With Amyotrophic Lateral Sclerosis (ALS) Completed
  2. Phase 2 Dyskinesia in Parkinson's Disease (Study P04501) Completed
  3. Phase 2 Follow Up Safety Study of SCH 420814 in Subjects With Parkinson's Disease (P05175) Completed
  4. Phase 2 Clinical Evaluation of Florbetapir F 18 (18F-AV-45) Completed
  5. N/A VA Cultivating Access to Resources, Education, and Skills for Dementia Caregivers Completed
  6. N/A Assessing a Novel Virtual Environment That Assists With Activities of Daily Living Completed
Show 5 more trials
  1. N/A Electronic-health Application To Measure Outcomes REmotely Clinical Trial Completed
  2. N/A Harmony at Home: A Pilot Telehealth Program for Rural ADRD Caregivers Completed
  3. N/A Smell, Voice and Nasal Swabs as Markers for Neuro-degenerative Disorders Completed
  4. N/A Evaluation of Web-based Training to Educate Physicians in the Methods of Interpreting Florbetapir-PET Scans Completed
  5. N/A Pilot Pragmatic Clinical Trial to Embed Tele-Savvy Into Health Care Systems Completed

Showing the 11 most-cited and recently-updated of 11 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Natural and synthetic compounds suppress inflammasome activation in NLRP3-driven pathologies
Allergy & Immunology Sys. Review
Natural and synthetic compounds suppress inflammasome activation in NLRP3-driven pathologies Your body has a built-in alarm system. It wakes up when you get a sore throat or a fever. But sometimes, this alarm gets stuck in the "on" position. That stuck alarm causes chronic pain and swelling. Scientists are finally learning how to turn it off
This systematic review examined molecular mechanisms involving natural compounds like oridonin and pristimerin, alongside synthetic inhibito…
A hidden protein key inside your cells triggers the stuck alarm that causes chronic pain and swelling, and scientists now know how to stop i…
Frontiers Apr 14, 2026
Disability benefit take-up varied by cause of death and geography in England and Wales
Palliative Care Cohort
Disability benefit take-up varied by cause of death and geography in England and Wales Millions Miss Out on Money Before Death
This retrospective cohort study examined 1,049,493 decedents aged 16 or older in England and Wales with chronic illnesses.
In England and Wales, one out of three people dying from expected causes like cancer or heart disease never receive the financial benefits t…
medRxiv Apr 14, 2026
Bioactive compounds and physical exercise may modulate hippocampal neurogenesis and cognitive resilience in aging and neurodegenerative disorders
Nutrition & Obesity Medicine Sys. Review
Bioactive compounds and physical exercise may modulate hippocampal neurogenesis and cognitive resilience in aging and neurodegenerative disorders Review finds early links between diet, exercise, and brain health in aging
This systematic review synthesizes mechanistic evidence from predominantly preclinical studies alongside emerging but comparatively limited …
Combining diet and exercise may boost brain plasticity and memory in aging by activating the neuro-nutritional-metabolic axis, though human …
Frontiers Apr 8, 2026
Greater cognitive variability in NSD Stage 2 predicts progression to advanced stages in observational study
Neurology
Greater cognitive variability in NSD Stage 2 predicts progression to advanced stages in observational study Could a simple test of mental consistency help spot early Parkinson's disease?
An observational study of 934 participants from the Parkinson's Progression Markers Initiative found that greater intraindividual cognitive …
A simple mental consistency test can spot early Parkinson's disease signs before obvious symptoms appear, helping predict who will progress …
medRxiv Apr 6, 2026
Systematic review suggests omega-3 deficiency may be modifiable risk factor for mental disorders
Neurology Sys. Review
Systematic review suggests omega-3 deficiency may be modifiable risk factor for mental disorders Review finds omega-3 fatty acid levels may be linked to brain health disorders
A systematic review of evidence across mental, neurodevelopmental, and neurodegenerative disorders suggests omega-3 deficiency and altered f…
Low omega-3 levels may act as a changeable risk factor for brain disorders like schizophrenia, ADHD, and Alzheimer's, offering a potential t…
Frontiers Apr 4, 2026

Questions about Neurodegenerative diseases

Can natural compounds like oridonin help stop inflammation in Neurodegenerative Disorders?

Natural compounds like oridonin show promise in stopping inflammation by targeting specific immune pathways, but more research is needed to confirm their use for neurodegenerative disorders.

Full answer →